Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinicopathologic features of TDO2 overexpression in renal cell carcinoma.
Pham QT, Taniyama D, Sekino Y, Akabane S, Babasaki T, Kobayashi G, Sakamoto N, Sentani K, Oue N, Yasui W. Pham QT, et al. Among authors: sentani k. BMC Cancer. 2021 Jun 26;21(1):737. doi: 10.1186/s12885-021-08477-1. BMC Cancer. 2021. PMID: 34174844 Free PMC article.
Clinicopathological significance of claspin overexpression and its efficacy as a novel biomarker for the diagnosis of urothelial carcinoma.
Kobayashi G, Hayashi T, Sentani K, Babasaki T, Sekino Y, Inoue S, Uraoka N, Hanamoto M, Nose H, Teishima J, Oue N, Matsubara A, Sasaki N, Yasui W. Kobayashi G, et al. Among authors: sentani k. Virchows Arch. 2022 Mar;480(3):621-633. doi: 10.1007/s00428-021-03239-7. Epub 2021 Nov 29. Virchows Arch. 2022. PMID: 34842980
DDX41 expression is associated with tumor necrosis in clear cell renal cell carcinoma and in cooperation with VHL loss leads to worse prognosis.
Kobatake K, Ikeda K, Nakata Y, Yamasaki N, Kanai A, Sekino Y, Takemoto K, Fukushima T, Babasaki T, Kitano H, Goto K, Hayashi T, Sentani K, Teishima J, Kaminuima O, Hinata N. Kobatake K, et al. Among authors: sentani k. Urol Oncol. 2022 Oct;40(10):456.e9-456.e18. doi: 10.1016/j.urolonc.2022.07.001. Epub 2022 Jul 30. Urol Oncol. 2022. PMID: 35918249
196 results